Market Cap

Biosynex SA Market Capitalization:

€10.8 Million

EUR as of Jan. 1, 2026

US$12.7 Million

business Biosynex SA Company Profile

Biosynex SA Main Stock Listings

Market Capitalization History of Biosynex SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Biosynex SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €10.8 M -41.62%
Jan. 1, 2025 €18.5 M -79.45%
Jan. 1, 2024 €90.2 M -36.59%
Jan. 1, 2023 €142.2 M -25.59%
Jan. 1, 2022 €191.1 M -10.30%
Jan. 1, 2021 €213.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Biosynex SA Categories

France languages Healthcare languages Diagnostics & Research
France Healthcare France Diagnostics & Research

Stocks & Indices

Biosynex SA has the following listings and related stock indices.


Stock: FSX: 0DL

Stock: Euronext: ALBIO

Stock: Euronext: BIOBS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.